GND 323
Alternative Names: GND-323Latest Information Update: 21 Jan 2025
Price :
$50 *
At a glance
- Originator Gandeeva Therapeutics
- Class Antineoplastics
- Mechanism of Action Protein-protein interaction modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer